Search

Christopher C. Caillouet

Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )

Most Active Art Unit
1745
Art Unit(s)
1791, 1745
Total Applications
862
Issued Applications
546
Pending Applications
67
Abandoned Applications
259

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7046258 [patent_doc_number] => 20050250853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Beta-tubulin inhibitors' [patent_app_type] => utility [patent_app_number] => 11/072334 [patent_app_country] => US [patent_app_date] => 2005-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8306 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250853.pdf [firstpage_image] =>[orig_patent_app_number] => 11072334 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/072334
Beta-tubulin inhibitors Mar 6, 2005 Abandoned
Array ( [id] => 5895473 [patent_doc_number] => 20060004012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders' [patent_app_type] => utility [patent_app_number] => 11/067377 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 41624 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20060004012.pdf [firstpage_image] =>[orig_patent_app_number] => 11067377 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/067377
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Feb 24, 2005 Issued
Array ( [id] => 6945312 [patent_doc_number] => 20050197361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors' [patent_app_type] => utility [patent_app_number] => 11/066899 [patent_app_country] => US [patent_app_date] => 2005-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33963 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197361.pdf [firstpage_image] =>[orig_patent_app_number] => 11066899 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/066899
Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors Feb 24, 2005 Issued
Array ( [id] => 5120723 [patent_doc_number] => 20070142438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine d3 receptors' [patent_app_type] => utility [patent_app_number] => 10/598200 [patent_app_country] => US [patent_app_date] => 2005-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54473 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142438.pdf [firstpage_image] =>[orig_patent_app_number] => 10598200 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/598200
Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D3 receptors Feb 20, 2005 Issued
Array ( [id] => 5101899 [patent_doc_number] => 20070185161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/598330 [patent_app_country] => US [patent_app_date] => 2005-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21610 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185161.pdf [firstpage_image] =>[orig_patent_app_number] => 10598330 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/598330
Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators Feb 17, 2005 Issued
Array ( [id] => 919804 [patent_doc_number] => 07320990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-22 [patent_title] => 'Crystalline form of a biphenyl compound' [patent_app_type] => utility [patent_app_number] => 11/057009 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20543 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/320/07320990.pdf [firstpage_image] =>[orig_patent_app_number] => 11057009 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/057009
Crystalline form of a biphenyl compound Feb 10, 2005 Issued
Array ( [id] => 7056469 [patent_doc_number] => 20050277644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Pyridine analogs as C5a antagonists' [patent_app_type] => utility [patent_app_number] => 11/053623 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11214 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277644.pdf [firstpage_image] =>[orig_patent_app_number] => 11053623 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/053623
Pyridine analogs as C5a antagonists Feb 7, 2005 Issued
Array ( [id] => 6959611 [patent_doc_number] => 20050215585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril' [patent_app_type] => utility [patent_app_number] => 11/053072 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3269 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215585.pdf [firstpage_image] =>[orig_patent_app_number] => 11053072 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/053072
Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril Feb 6, 2005 Issued
Array ( [id] => 243473 [patent_doc_number] => 07589208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Compositions containing quinoline compounds' [patent_app_type] => utility [patent_app_number] => 11/050441 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5930 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/589/07589208.pdf [firstpage_image] =>[orig_patent_app_number] => 11050441 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/050441
Compositions containing quinoline compounds Feb 3, 2005 Issued
Array ( [id] => 243473 [patent_doc_number] => 07589208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Compositions containing quinoline compounds' [patent_app_type] => utility [patent_app_number] => 11/050441 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5930 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/589/07589208.pdf [firstpage_image] =>[orig_patent_app_number] => 11050441 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/050441
Compositions containing quinoline compounds Feb 3, 2005 Issued
Array ( [id] => 243473 [patent_doc_number] => 07589208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Compositions containing quinoline compounds' [patent_app_type] => utility [patent_app_number] => 11/050441 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5930 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/589/07589208.pdf [firstpage_image] =>[orig_patent_app_number] => 11050441 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/050441
Compositions containing quinoline compounds Feb 3, 2005 Issued
Array ( [id] => 243473 [patent_doc_number] => 07589208 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-15 [patent_title] => 'Compositions containing quinoline compounds' [patent_app_type] => utility [patent_app_number] => 11/050441 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5930 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/589/07589208.pdf [firstpage_image] =>[orig_patent_app_number] => 11050441 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/050441
Compositions containing quinoline compounds Feb 3, 2005 Issued
Array ( [id] => 556594 [patent_doc_number] => 07468378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-23 [patent_title] => 'Substituted quinoline compounds' [patent_app_type] => utility [patent_app_number] => 11/049852 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 44968 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/468/07468378.pdf [firstpage_image] =>[orig_patent_app_number] => 11049852 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/049852
Substituted quinoline compounds Feb 2, 2005 Issued
Array ( [id] => 7051358 [patent_doc_number] => 20050187245 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-25 [patent_title] => 'Stable amorphous forms of montelukast sodium' [patent_app_type] => utility [patent_app_number] => 11/048746 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7622 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20050187245.pdf [firstpage_image] =>[orig_patent_app_number] => 11048746 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/048746
Stable amorphous forms of montelukast sodium Feb 2, 2005 Issued
Array ( [id] => 827008 [patent_doc_number] => 07402674 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-22 [patent_title] => '7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments' [patent_app_type] => utility [patent_app_number] => 11/042023 [patent_app_country] => US [patent_app_date] => 2005-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10490 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/402/07402674.pdf [firstpage_image] =>[orig_patent_app_number] => 11042023 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/042023
7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments Jan 24, 2005 Issued
Array ( [id] => 591021 [patent_doc_number] => 07435823 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/042634 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94409 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435823.pdf [firstpage_image] =>[orig_patent_app_number] => 11042634 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/042634
Compounds and methods of use Jan 23, 2005 Issued
Array ( [id] => 7595431 [patent_doc_number] => 07626030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Compounds and methods of use' [patent_app_type] => utility [patent_app_number] => 11/042398 [patent_app_country] => US [patent_app_date] => 2005-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32798 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/626/07626030.pdf [firstpage_image] =>[orig_patent_app_number] => 11042398 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/042398
Compounds and methods of use Jan 23, 2005 Issued
Array ( [id] => 292510 [patent_doc_number] => 07544803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Vanilloid receptor ligands and their use in treatments' [patent_app_type] => utility [patent_app_number] => 11/041173 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17269 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544803.pdf [firstpage_image] =>[orig_patent_app_number] => 11041173 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/041173
Vanilloid receptor ligands and their use in treatments Jan 20, 2005 Issued
Array ( [id] => 7234082 [patent_doc_number] => 20050256157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Combination therapy with CHK1 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/041191 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 150877 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256157.pdf [firstpage_image] =>[orig_patent_app_number] => 11041191 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/041191
Combination therapy with CHK1 inhibitors Jan 20, 2005 Abandoned
Array ( [id] => 7234082 [patent_doc_number] => 20050256157 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Combination therapy with CHK1 inhibitors' [patent_app_type] => utility [patent_app_number] => 11/041191 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 150877 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256157.pdf [firstpage_image] =>[orig_patent_app_number] => 11041191 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/041191
Combination therapy with CHK1 inhibitors Jan 20, 2005 Abandoned
Menu